EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha‐Amidating Monooxygenase Activity in Synovial Fibroblasts

Kevin J Sheridan iD, Emma R Dorris iD, Maria Inês Pimenta iD, Jemma Falkov, Matthew Fisher, Sam Pledger, Hector Devey iD, Munitta Muthana, Denis C Shields, Richard E Mains, Betty A Eipper, Christopher D Buckley und 1 weitere

Arthritis & Rheumatology · 2026-09 · 78 (9) · 1837-1849

DOI: 10.1002/art.70123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 14.04.2026. Verfasst von Kevin J Sheridan und 12 weiteren Autor:innen. Beteiligte Einrichtung: University College Dublin Centre for Arthritis Research, Conway Institute, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synovial Membrane, Fibroblasts, Mixed Function Oxygenases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Both susceptibility to, and severity of, rheumatoid arthritis (RA) is associated with the rs26232 C allele. Our primary aim was to identify the biologic mechanism underlying this association.

Methods

Expression of surrounding genes was compared among rs26232 genotypes. Publicly available databases were used to correlate expression with RA inflammation and single‐cell synovial distribution. Inhibition of gene expression and activity was achieved using small interfering RNA and a pharmacology agent and effects on RA synovial fibroblasts (RASFs) characteristics in vitro were assayed. The amidated secretome of synovial fibroblasts were characterized by mass spectrometry and enzyme‐linked immunosorbent assay. Effects of amidated peptides on macrophage polarity were determined using an RASF–macrophage coculture module. Results rs26232 C is associated with low expression of peptidylglycine alpha‐amidating monooxygenase ( PAM ) in multiple tissues including RASFs. Synovial PAM is highly expressed in RASFs but not immune cells, and levels are inversely correlated with synovial and systemic levels of inflammation. Inhibition of PAM in RASFs increased tissue‐damaging activities such as invasiveness in vitro. The most abundant amidated peptides secreted by RASFs were adrenomedullin (ADM) and pro‐ADM N‐terminal peptide (PAMP). Incubation of RASFs with either peptide inhibited interleukin‐6 (IL‐6) and IL‐8, increased transforming growth factor β production, and reduced invasiveness in vitro. Inhibition of amidation in an RASF–macrophage coculture model skewed the macrophages to proinflammatory MerTK − phenotypes.

Conclusion

Genetically determined low PAM reduces the anti‐inflammatory and tissue‐damaging activities of ADM and PAMP mediated by macrophages and RASFs, explaining the association of rs26232 C with RA severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSynovial MembraneFibroblastsMixed Function OxygenasesHumansMacrophagesCoculture TechniquesCells, CulturedInterleukin-6GenotypeGenetic Predisposition to DiseaseMultienzyme Complexes

Substanzen

peptidylglycine monooxygenaseMixed Function OxygenasesInterleukin-6Multienzyme Complexes

Autor:innen und Institutionen

  • University College Dublin Centre for Arthritis Research, Conway Institute, University College Dublin, Dublin, Ireland.
  • Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
  • Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
  • Department of Neuroscience, University of Connecticut Health Center, Farmington.

ORCID-Profile: Kevin J Sheridan, Emma R Dorris, Maria Inês Pimenta, Hector Devey, Anthony G Wilson

Förderung

  • Health Research Board

Zitieren

APA

Sheridan, K. J., Dorris, E. R., Pimenta, M. I., Falkov, J., Fisher, M., Pledger, S., Devey, H., Muthana, M., Shields, D. C., Mains, R. E., Eipper, B. A., Buckley, C. D., & Wilson, A. G. (2026). Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha‐Amidating Monooxygenase Activity in Synovial Fibroblasts. Arthritis & Rheumatology, 78(9), 1837-1849. https://doi.org/10.1002/art.70123

Vancouver

Sheridan KJ, Dorris ER, Pimenta MI, Falkov J, Fisher M, Pledger S, et al. Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha‐Amidating Monooxygenase Activity in Synovial Fibroblasts. Arthritis & Rheumatology. 2026;78(9):1837-1849. doi:10.1002/art.70123

BibTeX
@article{Sheridan2026,
  author = {Sheridan, Kevin J and Dorris, Emma R and Pimenta, Maria Inês and Falkov, Jemma and Fisher, Matthew and Pledger, Sam and Devey, Hector and Muthana, Munitta and Shields, Denis C and Mains, Richard E and Eipper, Betty A and Buckley, Christopher D and Wilson, Anthony G},
  title = {Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha‐Amidating Monooxygenase Activity in Synovial Fibroblasts},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  volume = {78},
  number = {9},
  pages = {1837--1849},
  doi = {10.1002/art.70123}
}
Kostenlos starten →